Novartis AG 2015 AR2
The report outlines Novartis' strategic and financial performance for the fiscal year 2015, highlighting the completion of its major business portfolio transformation. Key achievements include the launch of innovative treatments like Entresto and Cosentyx, alongside Sandoz's launch of Zarxio, the first approved biosimilar in the US. On the sustainability front, the company introduced the Novartis Access program to improve medicine affordability in developing countries and adopted new 2020 environmental targets, including a 30% reduction in greenhouse gas emissions compared to 2010. Additionally, Novartis implemented an internal carbon price of USD 100 per ton to incentivize low-carbon investments.
Company: Novartis AG
Sector: Manufacturing
Country: Switzerland
Year: 2015
Type: AR2
Pages: 264
Back to company
Novartis AG
Annual Report
The report outlines Novartis' strategic and financial performance for the fiscal year 2015, highlighting the completion of its major business portfolio transformation. Key achievements include the launch of innovative treatments like Entresto and Cosentyx, alongside Sandoz's launch of Zarxio, the first approved biosimilar in the US. On the sustainability front, the company introduced the Novartis Access program to improve medicine affordability in developing countries and adopted new 2020 environmental targets, including a 30% reduction in greenhouse gas emissions compared to 2010. Additionally, Novartis implemented an internal carbon price of USD 100 per ton to incentivize low-carbon investments.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2015
Reporting Period
Jan 1, 2015 - Dec 31, 2015
Fiscal Year
2015
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Women on Board
Women in Management
Employees